The global pulmonary drug delivery devices/systems market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of respiratory diseases and growing awareness about the benefits of pulmonary drug delivery devices/systems.
Metered dose inhalers are expected to be the fastest-growing segment in the global pulmonary drug delivery devices/systems market, with a CAGR of 5.2% during the forecast period, from 2021 to 2030. This growth can be attributed to factors such as increasing prevalence of respiratory diseases and growing awareness about the benefits of metered dose inhalers for asthma patients.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of chronic respiratory diseases such as asthma and COPD is driving the growth of the pulmonary drug delivery devices/systems market.
- The increasing number of patients with respiratory disorders is also driving the growth of this market.
- The growing awareness about pulmonary drug delivery devices/systems among physicians and patients is also a major factor that will drive the growth of this market in future years.
- Increasing research and development activities in this field are expected to fuel the growth of this market in future years.
- Increasing government funding for research on pulmonary drug delivery devices/systems will also fuel its growth.
Industry Growth Insights published a new data on “Pulmonary Drug Delivery Devices/Systems Market”. The research report is titled “Pulmonary Drug Delivery Devices/Systems Market research by Types (Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Accessories), By Applications (Hospitals and Clinics, Homecare), By Players/Companies Hovione, 3M Health Care, Bespak, BeyonDevices, GlaxoSmithKline, H&T Presspart, PARI Respiratory Equipment, Philips Respironics, SHL Group”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pulmonary Drug Delivery Devices/Systems Market Research Report
By Type
Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Accessories
By Application
Hospitals and Clinics, Homecare
By Companies
Hovione, 3M Health Care, Bespak, BeyonDevices, GlaxoSmithKline, H&T Presspart, PARI Respiratory Equipment, Philips Respironics, SHL Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Pulmonary Drug Delivery Devices/Systems Market Report Segments:
The global Pulmonary Drug Delivery Devices/Systems market is segmented on the basis of:
Types
Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Accessories
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Homecare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hovione
- 3M Health Care
- Bespak
- BeyonDevices
- GlaxoSmithKline
- H&T Presspart
- PARI Respiratory Equipment
- Philips Respironics
- SHL Group
Highlights of The Pulmonary Drug Delivery Devices/Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Accessories
- By Application:
- Hospitals and Clinics
- Homecare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pulmonary Drug Delivery Devices/Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pulmonary drug delivery devices/systems are medical devices that are inserted into the airways of patients to deliver medications directly to the lungs. Pulmonary drug delivery systems can be used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and pneumonia.
Some of the major players in the pulmonary drug delivery devices/systems market are Hovione, 3M Health Care, Bespak, BeyonDevices, GlaxoSmithKline, H&T Presspart, PARI Respiratory Equipment, Philips Respironics, SHL Group.
The pulmonary drug delivery devices/systems market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pulmonary Drug Delivery Devices/Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pulmonary Drug Delivery Devices/Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pulmonary Drug Delivery Devices/Systems Market - Supply Chain
4.5. Global Pulmonary Drug Delivery Devices/Systems Market Forecast
4.5.1. Pulmonary Drug Delivery Devices/Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pulmonary Drug Delivery Devices/Systems Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pulmonary Drug Delivery Devices/Systems Market Absolute $ Opportunity
5. Global Pulmonary Drug Delivery Devices/Systems Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Type
5.3.1. Metered Dose Inhalers
5.3.2. Dry Powder Inhalers
5.3.3. Nebulizers
5.3.4. Accessories
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pulmonary Drug Delivery Devices/Systems Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Application
6.3.1. Hospitals and Clinics
6.3.2. Homecare
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pulmonary Drug Delivery Devices/Systems Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pulmonary Drug Delivery Devices/Systems Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pulmonary Drug Delivery Devices/Systems Demand Share Forecast, 2019-2026
9. North America Pulmonary Drug Delivery Devices/Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Application
9.4.1. Hospitals and Clinics
9.4.2. Homecare
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Type
9.7.1. Metered Dose Inhalers
9.7.2. Dry Powder Inhalers
9.7.3. Nebulizers
9.7.4. Accessories
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pulmonary Drug Delivery Devices/Systems Demand Share Forecast, 2019-2026
10. Latin America Pulmonary Drug Delivery Devices/Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Application
10.4.1. Hospitals and Clinics
10.4.2. Homecare
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Type
10.7.1. Metered Dose Inhalers
10.7.2. Dry Powder Inhalers
10.7.3. Nebulizers
10.7.4. Accessories
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pulmonary Drug Delivery Devices/Systems Demand Share Forecast, 2019-2026
11. Europe Pulmonary Drug Delivery Devices/Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Application
11.4.1. Hospitals and Clinics
11.4.2. Homecare
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Type
11.7.1. Metered Dose Inhalers
11.7.2. Dry Powder Inhalers
11.7.3. Nebulizers
11.7.4. Accessories
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pulmonary Drug Delivery Devices/Systems Demand Share, 2019-2026
12. Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Application
12.4.1. Hospitals and Clinics
12.4.2. Homecare
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Type
12.7.1. Metered Dose Inhalers
12.7.2. Dry Powder Inhalers
12.7.3. Nebulizers
12.7.4. Accessories
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pulmonary Drug Delivery Devices/Systems Demand Share, 2019-2026
13. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Application
13.4.1. Hospitals and Clinics
13.4.2. Homecare
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Market Size and Volume Forecast by Type
13.7.1. Metered Dose Inhalers
13.7.2. Dry Powder Inhalers
13.7.3. Nebulizers
13.7.4. Accessories
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pulmonary Drug Delivery Devices/Systems Market: Market Share Analysis
14.2. Pulmonary Drug Delivery Devices/Systems Distributors and Customers
14.3. Pulmonary Drug Delivery Devices/Systems Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Hovione
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. 3M Health Care
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bespak
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. BeyonDevices
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GlaxoSmithKline
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. H&T Presspart
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. PARI Respiratory Equipment
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Philips Respironics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SHL Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
